Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
09/05/2000 | US6114515 PIGRL-1, a member of immunoglobulin gene superfamily |
09/05/2000 | US6114510 Process for the purification of recombinant human interleukin-8 |
09/05/2000 | US6114506 Composition and method for enhancing fibrinolysis |
09/05/2000 | US6114504 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins |
09/05/2000 | US6114503 A polynucleotide encoding a photolyase protein involved in dna repair; therapy for ultraviolet light damage |
09/05/2000 | US6114296 Cellulase variants |
09/05/2000 | US6114166 Human pluripotent hematopoietic colony stimulating factor and cell line producing same |
09/05/2000 | US6114160 Polynucleotide which codes for polypeptide of defined amino acid sequence which has taxadiene synthase activity; for recombinant production especially higher than normal gene expression in escherichia coli |
09/05/2000 | US6114148 High level expression of proteins |
09/05/2000 | US6114147 Immobilizing protein by modifying a fungus to produce a chimeric protein composed of a binding protein, a secretory signal peptide, and an anchoring portion; producing protein; transporting to cell wall; for separating target compounds |
09/05/2000 | US6114144 Isolation of a gene encoding human thyrotropin β subunit |
09/05/2000 | US6114143 Anti-HIV monoclonal antibody |
09/05/2000 | US6114140 Nucleotide sequences that code protein with enzymatic activity; for detecting proteins which bind hydrolase enzymes; antiproliferative agents; anticarcinogenic agents |
09/05/2000 | US6114123 Mammalian nucleic acid coding a extracellular transport protein; for the classification, diagnosis, prevention, and treatment of cell proliferative and immune defects |
09/05/2000 | US6113951 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins |
09/05/2000 | US6113917 Genetic polypeptides added to ceramide based lipid-glycan anchor structure |
09/05/2000 | US6113914 Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines |
09/05/2000 | US6113912 Hepatitis A virus vaccines |
09/05/2000 | US6113911 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method |
09/05/2000 | US6113903 Antidiabetic agents |
09/05/2000 | US6113901 Immunopotentiating cd-3 antigen monoclonal antibodies |
09/05/2000 | US6113899 Antagonists of chaperonin 10 |
09/05/2000 | US6113898 Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies |
09/05/2000 | US6113896 Serine protease inhibitors which inhibit factor x |
09/05/2000 | CA2098183C Method for the purification of intact, correctly-folded insulin-like growth factor-1 |
09/05/2000 | CA2057058C Monoclonal antibodies to c-reactive protein |
09/05/2000 | CA2013240C Strain of saccharomyces cerevisiae producing an heterologous protein and process for the preparation of said heterologous protein by fermentation of said strain |
09/05/2000 | CA2006549C In vivo recombination of partially homologous dna sequences |
09/05/2000 | CA1341094C Diagnosis for malignant hyperthermia |
09/05/2000 | CA1341092C Process for altering the host range of bacillus thuringiensis toxins, and novel toxins produced thereby |
08/31/2000 | WO2000050627A1 Monkey gonadotropin releasing hormone receptor |
08/31/2000 | WO2000050611A1 Ganp proteins |
08/31/2000 | WO2000050610A1 Genetically engineered microorganisms useful in expression of bioproducts from starch waste |
08/31/2000 | WO2000050608A1 Novel polypeptide |
08/31/2000 | WO2000050607A2 Goodpasture antigen binding protein |
08/31/2000 | WO2000050603A1 Attenuated chicken-pox virus oka strain gene 62 and method for identifying virus strain for attenuated live chicken-pox vaccine by using the gene |
08/31/2000 | WO2000050597A2 Neutrokine-alpha and neutrokine-alpha splice variant |
08/31/2000 | WO2000050596A2 14273 receptor, a novel g-protein coupled receptor |
08/31/2000 | WO2000050586A2 In vitro translation system |
08/31/2000 | WO2000050580A2 Composition, methods and reagents for the synthesis of a soluble form of human phex |
08/31/2000 | WO2000050566A2 Genes encoding insect odorant receptors and uses thereof |
08/31/2000 | WO2000050562A2 Dna encoding snorf25 receptor |
08/31/2000 | WO2000050449A1 Process for production diphtheria toxin |
08/31/2000 | WO2000050445A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase |
08/31/2000 | WO2000050443A2 Secreted proteins and uses thereof |
08/31/2000 | WO2000050087A1 Glycoconjugates obtained from candida utilis cells and ricinus communis seeds |
08/31/2000 | WO2000049887A1 Method for preparing an albumin isolate from a substance containing albumin |
08/31/2000 | WO2000049886A1 Method for preparing albumin hydrolysates |
08/31/2000 | WO2000043492A8 Method of site specific labeling of proteins and uses therefor |
08/31/2000 | WO2000028038A3 Virulence genes and proteins, and their use |
08/31/2000 | WO2000028029A3 Cell surface glycoproteins |
08/31/2000 | WO2000025805A8 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
08/31/2000 | WO2000023472A3 Interferon-beta fusion proteins and uses |
08/31/2000 | WO2000021552A9 Glycoprotein antigens, antibodies specific thereto and method for producing same |
08/31/2000 | WO2000018932A9 Receptor based antagonists and methods of making and using |
08/31/2000 | WO2000018923A9 Slgp protein and nucleic acid molecule and uses therefor |
08/31/2000 | WO2000018914A3 Novel dkr polypeptides |
08/31/2000 | WO2000018910A9 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
08/31/2000 | WO2000018904A9 Secreted proteins and nucleic acids encoding them |
08/31/2000 | WO2000018803A3 Antibodies to mammalian langerhans cell antigen and their uses |
08/31/2000 | CA2365019A1 Novel polypeptide |
08/31/2000 | CA2364966A1 Genes encoding insect odorant receptors and uses thereof |
08/31/2000 | CA2364925A1 Monkey gonadotropin releasing hormone receptor |
08/31/2000 | CA2364921A1 Translation system |
08/31/2000 | CA2363794A1 14273 receptor, a novel g-protein coupled receptor |
08/31/2000 | CA2363112A1 Neutrokine-alpha and neutrokine-alpha splice variant |
08/31/2000 | CA2363095A1 Glycoconjugates obtained from candida utilis cells and ricinus communis seeds |
08/31/2000 | CA2362948A1 Method for preparing an albumin isolate from a substance containing albumin |
08/31/2000 | CA2362906A1 Dna encoding snorf25 receptor |
08/31/2000 | CA2362520A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase |
08/30/2000 | EP1031835A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases. |
08/30/2000 | EP1031628A1 Process for the production of protease inhibitors |
08/30/2000 | EP1031578A2 High purity albumin production by a multistep process |
08/30/2000 | EP1030928A1 Development of viruses resistant to inactivation by the human complement system |
08/30/2000 | EP1030925A1 The translation enhancer element of the human amyloid precursor protein gene |
08/30/2000 | EP1030919A2 Cdk2 protein and cdk2 protein complexes |
08/30/2000 | EP1030917A1 Transcriptionally regulated g protein-coupled receptor |
08/30/2000 | EP1030916A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
08/30/2000 | EP1030915A1 A novel gene and uses therefor |
08/30/2000 | EP1030911A1 Human aspartic proteases |
08/30/2000 | EP1030865A2 Th2 CELL DEPLETION; COMPOSITIONS; METHODS |
08/30/2000 | EP1030859A1 Ras-binding protein (pre1) |
08/30/2000 | EP1030858A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport |
08/30/2000 | EP1030683A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
08/30/2000 | EP0671946B1 Immunoreactive peptides from epstein-barr virus |
08/30/2000 | EP0642348B1 Antibiotic cryptdin peptides and methods of their use |
08/30/2000 | EP0248819B2 Recombinant fibroblast growth factors |
08/30/2000 | CN1265156A Amplification and other enzymatic reactions preformed on nucleic acid arrays |
08/30/2000 | CN1265143A Prodn. of erythropoietin by endogenous gene activation |
08/30/2000 | CN1264740A Human UMP-CMP kinase and its coding sequence, preparing process and application |
08/30/2000 | CN1264739A Human protein and its coding sequence, preparing process and application |
08/29/2000 | US6111166 Transgenic mice expressing human Fcα and β receptors |
08/29/2000 | US6111165 Production of human recombinant collagen in the milk of transgenic animals |
08/29/2000 | US6111091 Nucleotide sequence of ionotropic glutamate receptor; probes to identify and isolate related human receptor subunits; drug screening assays to identify agonists, antagonists, and modulators |
08/29/2000 | US6111089 Nucleic acid encoding a defined mouse amino acid sequence of a protein involved in embryo implantation; vaccine can be used as antifertility agent |
08/29/2000 | US6111081 Lactoferrin variants and uses thereof |
08/29/2000 | US6111076 Human G-protein coupled receptor (HIBCD07) |
08/29/2000 | US6111074 Amino acid sequence of polypeptide from the uridine monophosphate kinase family; for screening bactericides and bacteriostats; for diagnosis and prophylaxis of infections |
08/29/2000 | US6111066 Peptidic molecules which have been isotopically substituted with 13 C, 15 N and 2 H in the backbone but not in the sidechains |
08/29/2000 | US6110899 LICC of Streptococcus pneumoniae |